Arab Tunisian Lease S.A. (BVMT:ATL)

CTI BioPharma Ratios and Metrics

Market cap in millions TND. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	195	138	117	98	59	52
Market Cap Growth	167.30%	18.06%	20.00%	64.83%	14.46%	-6.47%
Enterprise Value	620	517	464	464	458	495
Last Close Price	6.00	4.00	3.13	2.43	1.35	1.13
PE Ratio	8.82	6.25	5.86	5.99	5.31	9.79
Forward PE	8.96	8.25	7.42	9.52	-	-
PS Ratio	1.99	1.41	1.32	1.24	0.79	0.74
PB Ratio	1.36	0.96	0.89	0.81	0.54	0.51
P/TBV Ratio	1.36	0.96	0.89	0.81	0.54	0.51
P/FCF Ratio	22.80	16.15	-	1.24	-	5.66
P/OCF Ratio	11.21	7.94	-	1.14	-	4.70
EV/Sales Ratio	6.34	5.29	5.22	5.91	6.10	7.06
EV/EBITDA Ratio	8.19	6.83	6.87	8.38	8.85	9.68
EV/EBIT Ratio	8.25	6.88	6.92	8.45	8.94	9.80
EV/FCF Ratio	72.53	60.46	-	5.90	-	54.25
Debt / Equity Ratio	3.28	3.28	3.53	3.38	4.28	4.41
Debt / EBITDA Ratio	6.22	6.22	6.86	7.31	9.13	8.76
Debt / FCF Ratio	55.08	55.08	-	5.15	-	49.10
Asset Turnover	0.14	0.14	0.14	0.12	0.12	0.11
Quick Ratio	6.58	6.58	7.26	5.90	8.50	7.73
Current Ratio	6.60	6.60	7.33	5.95	8.63	7.94
Return on Equity (ROE)	16.09%	16.09%	15.90%	14.13%	10.51%	5.33%
Return on Assets (ROA)	6.67%	6.67%	6.35%	5.31%	4.95%	5.05%
Return on Capital (ROIC)	7.77%	7.77%	7.48%	6.20%	5.65%	5.72%
Return on Capital Employed (ROCE)	12.10%	12.10%	11.20%	10.30%	8.70%	9.10%
Earnings Yield	11.34%	16.01%	17.07%	16.69%	18.82%	10.22%
FCF Yield	4.39%	6.19%	-42.53%	80.73%	-64.94%	17.66%
Dividend Yield	5.00%	-	9.59%	11.11%	-	6.65%
Payout Ratio	44.09%	44.09%	43.93%	39.95%	21.90%	-
Buyback Yield / Dilution	-	-	-	-	-	-13.04%
Total Shareholder Return	5.00%	-	9.59%	11.11%	-	-6.40%

Updated Mar 25, 2022. Source: S&P Global Market Intelligence. Standard template. Financial Sources.